Submissions from 2025
Infusion Reactions with Alternative Therapies During the National Shortage of Iron Dextran, Brigid Jacob, Maria Jamil, Shahm Raslan, Kylie Springer, Zeinab Nasser, and Philip Kuriakose
Submissions from 2024
Clinical Trials for Patients With Cancer, Fawzi Abu Rous, Aakash Desai, and Eric K. Singhi
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer, Janet A. Alvarez, Qian Shi, Arvind Dasari, Julio Garcia-Aguilar, Hanna Sanoff, Thomas J. George, Theodore Hong, Greg Yothers, Philip A. Philip, Garth Nelson, Tareq Al Baghdadi, Olatunji B. Alese, Wini Zambare, Dana Omer, Floris S. Verheij, Aron Bercz, Min Jung Kim, James Buckley, Hannah Williams, Manju George, Reese Garcia, Phuong Gallagher, Eileen M. O'Reilly, Jeffrey A. Meyerhardt, Jamie Crawley, Ardaman Shergill, Natally Horvat, Paul B. Romesser, William Hall, and J. Joshua Smith
RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth, Sahar F. Bannoura, Amro Aboukameel, Husain Yar Khan, Md Hafiz Uddin, Hyejeong Jang, Eliza W. Beal, Amalraj Thangasamy, Yang Shi, Seongho Kim, Kay-Uwe Wagner, Rafic Beydoun, Bassel F. El-Rayes, Philip A. Philip, Ramzi M. Mohammad, Muhammad Wasif Saif, Mohammed Najeeb Al-Hallak, Boris C. Pasche, and Asfar S. Azmi
Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice, Ivana Barravecchia, Jennifer M. Lee, Jason Manassa, Brian Magnuson, Sarah F. Ferris, Sophia Cavanaugh, Nina G. Steele, Carlos E. Espinoza, Craig J. Galban, Nithya Ramnath, Timothy L. Frankel, Marina Pasca di Magliano, and Stefanie Galban
ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma, Simone Benitz, Alec Steep, Malak M. Nasser, Jonathan Preall, Ujjwal Mukund Mahajan, Holly McQuithey, Ian Loveless, Erick T. Davis, Hui-Ju Wen, Daniel W. Long, Thomas Metzler, Samuel Zwernik, Michaela Louw, Donald Rempinski, Daniel J. Salas-Escabillas, Sydney M. Brender, Linghao Song, Ling Huang, Brian K. Theisen, Zhenyu Zhang, Nina G. Steele, Ivonne Regel, Filip Bednar, and Howard C. Crawford
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer, Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Pedro C. Barata, Frank Cameron Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet Asim Bilen, Deepak Kilari, Bicky Thapa, Michael Piero, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S. Koshkin, Erik Hernandez, Tanya B. Dorff, Michael Thomas Schweizer, Ajjai Shivaram Alva, Rana R. McKay, and Andrew J. Armstrong
Assessment of prostate tissue remodeling in rats exposed to bisphenol A and the phytoestrogens genistein and indole-3-carbinol during the perinatal period, Ericka S. B. Bueno, Carlos D. V. Neto, Alessandro Rodrigues, Thaina C. Sousa, Karianne D. Hinokuma, Ariana M. de Aquino, Wllerson R. Scarano, Joyce Z. Brandt, and Leonardo de Oliveira Mendes
Pancreatic Cancer-Associated Fibroblasts: Where do we go from here?, Eileen S. Carpenter, Débora Barbosa Vendramini Costa, Marie C. Hasselluhn, Anirban Maitra, Kenneth P. Olive, Edna Cukierman, Marina Pasca di Magliano, and Mara H. Sherman
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study, Cecilia A. Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R. K Singh, Elizabeth A. Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I. Cárdenas-Delgado, Rana R. McKay, Taylor K. Nonato, Archana Ajmera, Peter P. Yu, Rajani Nadkarni, Timothy E. O'Connor, Stephanie Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M. Saliby, Chris Labaki, Talal El Zarif, Trisha M. Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E. Bodin, Melissa K. Accordino, Matthew Ingham, Monika Joshi, Hyma V. Polimera, Leslie A. Fecher, Christopher R. Friese, James J. Yoon, Blanche H. Mavromatis, Jacqueline T. Brown, Karen Russell, Rahul Nanchal, Harpreet Singh, Lisa Tachiki, Feras A. Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H. Abbasi, Elizabeth M. Wulff-Burchfield, Matthew Puc, Lisa B. Weissmann, Padmanabh S. Bhatt, Melissa G. Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L. Warner, Benjamin French, and Mehmet A. Bilen
Non-alcoholic Wernicke's Encephalopathy Masquerading As CNS Relapse of Acute Myeloid Leukemia, Ammad J. Chaudhary, Katherine M. Joyce, Kamran Haq, Muhammad H. Qureshi, and Vijayalakshmi Donthireddy
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC, Byoung C. Cho, Shun Lu, Enriqueta Felip, Alexander I. Spira, Nicolas Girard, Jong-Seok Lee, Se-Hoon Lee, Yurii Ostapenko, Pongwut Danchaivijitr, Baogang Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Benjamin Besse, Ki-Hyeong Lee, Hailin Xiong, Soon-Hin How, Ying Cheng, Gee-Chen Chang, Hiroshige Yoshioka, James C-H Yang, Michael Thomas, Danny Nguyen, Sai-Hong I. Ou, Sanjay Mukhedkar, Kumar Prabhash, Manolo D'Arcangelo, Jorge Alatorre-Alexander, Juan C. Vázquez Limón, Sara Alves, Daniil Stroyakovskiy, Marina Peregudova, Mehmet A. N. Şendur, Ozan Yazici, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Antonio Passaro, Sang-We Kim, Shirish M. Gadgeel, John Xie, Tao Sun, Melissa Martinez, Mariah Ennis, Elizabeth Fennema, Mahesh Daksh, Dawn Millington, Isabelle Leconte, Ryota Iwasawa, Patricia Lorenzini, Mahadi Baig, Sujay Shah, Joshua M. Bauml, S. Martin Shreeve, Seema Sethi, Roland E. Knoblauch, and Hidetoshi Hayashi
Failure to Undergo Resection Following Neoadjuvant Therapy for Resectable Pancreatic Cancer: A Secondary Analysis of SWOG S1505, Jordan M. Cloyd, Sarah Colby, Katherine A. Guthrie, Andy M. Lowy, E. Gabrielle Chiorean, Philip A. Philip, Davendra Sohal, and Syed Ahmad
Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1, Anagha Deshpande, Javier Munoz, Vrushali Dabak, Amr Hanbali, and Razelle Kurzrock
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update, Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, Maria Eugenia Olmedo, Michael Boyer, Kai He, Neeltje Steeghs, Hiroki Izumi, Melissa L. Johnson, Tatsuya Yoshida, Hasna Bouchaab, Hossein Borghaei, Enriqueta Felip, Philipp J. Jost, Shirish M. Gadgeel, Xi Chen, Youfei Yu, Pablo Martinez, Amanda Parkes, and Luis Paz-Ares
High-dose alectinib for RET fusion-positive non-small cell lung cancer in the Blood First Assay Screening Trial, Rafal Dziadziuszko, Nir Peled, Tony Mok, Solange Peters, Santiago Ponce Aix, Jorge Alatorre-Alexander, Brian D. Vicuna, Margaret Maclennan, Vijay Bhagawati-Prasad, Sarah M. Shagan, Erica Schleifman, Thorsten Ruf, Michael S. Mathisen, and Shirish M. Gadgeel
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA, E. Felip, B. C. Cho, V. Gutiérrez, A. Alip, B. Besse, S. Lu, A. I. Spira, N. Girard, R. Califano, Shirish M. Gadgeel, J. C-H Yang, S. Yamamoto, K. Azuma, Y. J. Kim, K-H Lee, P. Danchaivijitr, C. G. Ferreira, Y. Cheng, M. A. N. Sendur, G-C Chang, C-C Wang, K. Prabhash, Y. Shinno, D. Stroyakovskiy, L. Paz-Ares, J. R. Rodriguez-Cid, C. Martin, M. R. G. Campelo, H. Hayashi, D. Nguyen, P. Tomasini, M. Gottfried, C. Dooms, A. Passaro, M. Schuler, A. C. Z. Gelatti, S. Owen, K. Perdrizet, S-H I. Ou, J. C. Curtin, J. Zhang, M. Gormley, T. Sun, A. Panchal, M. Ennis, E. Fennema, M. Daksh, S. Sethi, J. M. Bauml, and S-H Lee
Proceedings of the 1st biannual bridging the gaps in lung cancer conference, Narjust Florez, Sandip P. Patel, Heather Wakelee, Lyudmila Bazhenova, Erminia Massarelli, Ravi Salgia, Brendon Stiles, Solange Peters, Jyoti Malhotra, Shirish M. Gadgeel, Jorge J. Nieva, Michelle Afkhami, Fred R. Hirsch, Matthew Gubens, Tina Cascone, Benjamin Levy, Joshua Sabari, Hatim Husain, Patrick C. Ma, Leah M. Backhus, Puneeth Iyengar, Percy Lee, Russell Miller, Jacob Sands, and Edward Kim
Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer, Ralph Francescone, Howard C. Crawford, and Débora Barbosa Vendramini Costa
Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting, Shirish M. Gadgeel, Pragya Rai, Srinivas Annavarapu, Sartaj Alam, Jerome H. Goldschmidt, Howard Jack West, Melissa Santorelli, and Renata Eiras Martins
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up, Shirish M. Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, Marina C. Garassino, Takayasu Kurata, Ying Cheng, Erin Jensen, Mark Shamoun, Kumar Rajagopalan, and Luis Paz-Ares
Further Probing the Properties of a Unique Sponge-derived Alkaloid Through the Isolation of a New (-)-(5E)-(8R)-(14Z)-Mycothiazole Analogue, Joe A Gerke, Sofia F Odron, Juri Kim, Naibedya Dutta, Jacqueline G Clarke, Joe Media, David A Coppage, Maria Oorloff, Athena Alcala, Gilberto Garcia, Marissa E F Kang, Cy L Gerke, Jacob C Peterson, Joseph D Morris, Ryo Higuchi-Sanabria, Frederick A Valeriote, Phillip Crews, and Tyler A Johnson
Small molecular inhibitors: Therapeutic strategies for pancreatic cancer, Yuvasri Golivi, Seema Kumari, Batoul Farran, Afroz Alam, Sujatha Peela, and Ganji Purnachandra Nagaraju
ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report, Luis F. Gonzalez Mosquera, Fawzi Abu Rous, Alexandra Rogers, Nicolina Smith, Gregory Goyert, and Shirish M. Gadgeel
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study, Julie N. Graff, Christopher J. Hoimes, Winald R. Gerritsen, Ulka N. Vaishampayan, Tony Elliott, Clara Hwang, Albert J. Ten Tije, Aurelius Omlin, Raymond S. McDermott, Yves Fradet, Scott T. Tagawa, Deepak Kilari, Cristiano Ferrario, Hiroji Uemura, Robert J. Jones, Satoshi Fukasawa, Avivit Peer, Cuizhen Niu, Christian H. Poehlein, Ping Qiu, Leah Suttner, Ronald de Wit, Charles Schloss, Johann S. de Bono, and Emmanuel S. Antonarakis
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes, Laura S. Graham, Nicholas C. Henderson, Olesia Kellezi, Clara Hwang, Pedro C. Barata, Mehmet A. Bilen, Deepak Kilari, Michael Pierro, Bicky Thapa, Abhishek Tripathi, George Mo, Matthew Labriola, Joseph J. Park, Shoshana Rothstein, Rohan Garje, Vadim S. Koshkin, Vaibhav G. Patel, Tanya Dorff, Andrew J. Armstrong, Rana R. McKay, Ajjai Alva, and Michael T. Schweizer
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma, Omid Hamid, Karl D. Lewis, Amy Weise, Meredith McKean, Kyriakos P. Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S. Thomas, Janice Mehnert, John Kaczmar, Nehal J. Lakhani, Kevin B. Kim, Mark R. Middleton, Guilherme Rabinowits, Alexander I. Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne Paccaly, Sheila Masinde, Mark Salvati, Matthew G. Fury, Glenn Kroog, Israel Lowy, and Giuseppe Gullo
For Squamous Cancers, the Streetlamps Shine on Occasional Keys, Most Baskets Are Empty, and the Umbrellas Cannot Keep Us Dry: A Call for New Models in Precision Oncology, D. Neil Hayes, Oluchukwu Oluoha, and David L. Schwartz
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate Cancer, Elisabeth I. Heath, Archana Thakur, Wei Chen, Clara Hwang, Channing J. Paller, Frank C. Cackowski, Julie L. Boerner, Lance Heilbrun, Melanie P. Smith, Dana L. Schalk, Amy Schienschang, Sarah A. Whitaker, Amanda Polend, Daryn Smith, Ulka N. Vaishampayan, Brenda Dickow, and Lawrence G. Lum
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study, Tania Jain, Noel Estrada-Merly, M. Queralt Salas, Soyoung Kim, Jakob DeVos, Min Chen, Xi Fang, Rajat Kumar, Marcio Andrade-Campos, Hany Elmariah, Vaibhav Agrawal, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Vijaya Raj Bhatt, Christopher Bredeson, Zachariah DeFilipp, Bhagirathbhai Dholaria, Nosha Farhadfar, Shatha Farhan, Arpita P. Gandhi, Siddhartha Ganguly, Usama Gergis, Michael R. Grunwald, Nada Hamad, Betty K. Hamilton, Yoshihiro Inamoto, Madiha Iqbal, Omer Jamy, Mark Juckett, Mohamed A. Kharfan-Dabaja, Maxwell M. Krem, Deepesh P. Lad, Jane Liesveld, Monzr M. Al Malki, Adriana K. Malone, Hemant S. Murthy, Guillermo Ortí, Sagar S. Patel, Attaphol Pawarode, Miguel-Angel Perales, Marjolein van der Poel, Olle Ringden, David A. Rizzieri, Alicia Rovó, Bipin N. Savani, Mary Lynn Savoie, Sachiko Seo, Melhem Solh, Celalettin Ustun, Leo F. Verdonck, John R. Wingard, Baldeep Wirk, Nelli Bejanyan, Richard J. Jones, Taiga Nishihori, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber, and Vikas Gupta
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3, Ishmael A. Jaiyesimi, Natasha B. Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish M. Gadgeel, Gregory Masters, Erin L. Schenk, Bryan J. Schneider, Lecia Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E. Reuss, David R. Spigel, Dwight H. Owen, and Jyoti D. Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3, Ishmael A. Jaiyesimi, Natasha B. Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish M. Gadgeel, Gregory Masters, Erin L. Schenk, Bryan J. Schneider, Lecia Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E. Reuss, David R. Spigel, Dwight H. Owen, and Jyoti D. Patel
Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC, Elaine M. Jennings, D. Ross Camidge, Shirish M. Gadgeel, and Scott Barker
Genetic African Ancestry Modifies the Biology of Acute Myeloid Leukemia, Evelyn M. Jiagge
Sezary Syndrome: A Case Report and Review of Current Therapeutics, Jayasree Krishnan and Kannan Thanikachalam
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis, Amit A. Kulkarni, Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang, Joy Awosika, Ziad Bakouny, Hina Khan, Diana Vilar-Compte, Rana McKay, Chinmay Jani, Lisa Weissmann, Elizabeth Griffiths, Gerald Batist, Nathaniel Bouganim, Blanche Mavromatis, Babar Bashir, Ryan H Nguyen, Jonathan W Riess, Matthew Puc, Anup Kasi, Stephanie Berg, Dan Ran Castillo, Brandon Hayes-Lattin, Wylie Hosmer, Daniel Flora, Sanjay Mishra, Benjamin French, Jeremy L. Warner, Gilberto Lopes, Solange Peters, and Narjust Florez
Zinc Finger Nuclease-Mediated Gene Editing in Hematopoietic Stem Cells Results in Reactivation of Fetal Hemoglobin in Sickle Cell Disease, Samuel Lessard, Pauline Rimmelé, Hui Ling, Kevin Moran, Benjamin Vieira, Yi-Dong Lin, Gaurav Manohar Rajani, Vu Hong, Andreas Reik, Richard Boismenu, Ben Hsu, Michael Chen, Bettina M Cockroft, Naoya Uchida, John Tisdale, Asif Alavi, Lakshmanan Krishnamurti, Mehrdad Abedi, Isobelle Galeon, David Reiner, Lin Wang, Anne Ramezi, Pablo Rendo, Mark C Walters, Dana Levasseur, Robert Peters, Timothy Harris, and Alexandra Hicks
Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials, RamaRao Malla, Mundla Srilatha, Veda Muppala, Batoul Farran, Virander Singh Chauhan, and Ganji Purnachandra Nagaraju
Tumor-Associated Carbohydrate Antigen 19-9 (CA 19-9), a Promising Target for Antibody-Based Detection, Diagnosis, and Immunotherapy of Cancer, Athar Nakisa, Lorenzo F. Sempere, Xi Chen, Linda T. Qu, Daniel Woldring, Howard C. Crawford, and Xuefei Huang
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT), Nitin Ohri, Shruti Jolly, Benjamin T. Cooper, Rafi Kabarriti, William R. Bodner, Jonathan Klein, Chandan Guha, Shankar Viswanathan, Elaine Shum, Joshua K. Sabari, Haiying Cheng, Rasim A. Gucalp, Enrico Castellucci, Angel Qin, Shirish M. Gadgeel, and Balazs Halmos
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations, Joseph J. Park, Alec Chu, Jinju Li, Alicia Ali, Rana R. McKay, Clara Hwang, Matthew K. Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S. Graham, Alexandra Sokolova, Abhishek Tripathi, Amanda Pilling, Tanya Jindal, Aditya Ravindra, Frank C. Cackowski, Patrick L. Sweeney, Bicky Thapa, Taylor S. Amery, Elisabeth I. Heath, Rohan Garje, Yousef Zakharia, Vadim S. Koshkin, Mehmet A. Bilen, Michael T. Schweizer, Pedro C. Barata, Tanya B. Dorff, Marcin Cieslik, Ajjai S. Alva, and Andrew J. Armstrong
Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors, Sandip P. Patel, Teresa Alonso-Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan E. Standifer, Doug C. Palmer, Lin-Yang Cheng, Panagiotis Kourtesis, Maria L. Ascierto, Mayukh Das, Jennifer R. Diamond, Matthew D. Hellmann, and Benedito A. Carneiro
Herbal and Non-Herbal Dietary Supplements for Psychiatric Indications: Considerations in Liver Transplantation, Shivali Patel, Kinza Tareen, Chandni Patel, and Amy Rosinski
Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial, Solange Peters, Shirish M. Gadgeel, Tony Mok, Ernest Nadal, Saadettin Kilickap, Aurélie Swalduz, Jacques Cadranel, Shunichi Sugawara, Chao-Hua Chiu, Chong-Jen Yu, Mor Moskovitz, Tomohiro Tanaka, Rhea Nersesian, Sarah M. Shagan, Margaret Maclennan, Michael Mathisen, Vijay Bhagawati-Prasad, Cheick Diarra, Zoe June Assaf, Venice Archer, and Rafal Dziadziuszko
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study, Philip A. Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi, Caio Max S Rocha Lima, Angela T. Alistar, Paul E. Oberstein, Talia Golan, Jean-Philippe Metges, Jill Lacy, Christos Fountzilas, Charles D. Lopez, Michel Ducreux, Pascal Hammel, Mohamed Salem, David Bajor, Al B. Benson, Sanjeev Luther, Timothy Pardee, and Eric Van Cutsem
CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma, Priyanka A. Pophali, Joshua A. Fein, Kwang W. Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T. Awan, Shatha Farhan, Natalie S. Grover, Talal Hilal, Madiha Iqbal, Joseph Maakaron, Dipenkumar Modi, Elham Nasrollahi, Levanto G. Schachter, Craig Sauter, Mehdi Hamadani, Alex Herrera, Roni Shouval, and Mazyar Shadman
Increased Fatigability and Impaired Skeletal Muscle Microvascular Reactivity in Adults with Obstructive Sleep Apnea: A Cross-Sectional Study, Shipra Puri, Monira Aldhahi, Lisa M K Chin, Andrew A Guccione, Vivek Jain, and Jeffrey E Herrick
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer, Angel Qin, Leah Wells, Binu Malhotra, Shirish M. Gadgeel, Bryan J. Schneider, Nithya Ramnath, John D. Rice, and Gregory P. Kalemkerian
EVERYTHING YOU NEED TO KNOW ABOUT MENTORING TO ACHIEVE YOUR CAREER GOALS: A COMPREHENSIVE MENTORSHIP WORKBOOK, Dionisia Quiroga, Fawzi Abu Rous, Rajat Thawani, Dawood Findakly, Fionnuala Crowley, Anusha Chidharla, and Muhammad Salman Faisal
Observational cohort study of long-term outcomes of liver transplantation in haemophilia, Margaret V. Ragni, Jessica Callis, Nabil Daoud, Brian Hu, Matthew Manuel, Jarren Santos, Jonathan Schwartz, Kenneth D. Friedman, Peter Kouides, Philip Kuriakose, Andrew D. Leavitt, Ming Y. Lim, Nicoletta Machin, Michael Recht, and Tammuella Chrisentery-Singleton
At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer, Theresa Schwartz
Axillary nodal staging in breast cancer: what have we learned?, Theresa L. Schwartz
A Retrospective Study of Fertility Counseling and Preservation Rates for Women of Reproductive Age With Breast Care After Integrating a Fertility Specialist Into a Multidisciplinary Tumor Board, Monique Swain, Madison Miller, Cara Cannella, Samfee Doe, Lindsay Petersen, and Jessica Bensenhaver
Deciphering cellular plasticity in pancreatic cancer for effective treatments, Md Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El-Rayes, Herbert Chen, Philip A. Philip, and Asfar S. Azmi
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma, Max M. Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, Yuqing Xue, Renee Chang, Devora Delman, Jesse Lee, Kajsa Affolter, Sean J. Mulvihill, M. Shaalan Beg, Andrea Wang-Gillam, James Lloyd Wade, Katherine A. Guthrie, E. Gabriela Chiorean, Syed A. Ahmad, Andrew M. Lowy, Philip A. Philip, Davendra P. S Sohal, and Gregory L. Beatty
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation, Rona Yaeger, Meredith A. McKean, Rizwan Haq, J. Thaddeus Beck, Matthew H. Taylor, Jonathan Eliezer Cohen, Daniel W. Bowles, Shirish M. Gadgeel, Catalin Mihalcioiu, Kyriakos P. Papadopoulos, Eli L. Diamond, Keren B. Sturtz, Gang Feng, Stefanie K. Drescher, Micaela B. Reddy, Bhaswati Sengupta, Arnab K. Maity, Suzy A. Brown, Anurag Singh, Eric N. Brown, Brian R. Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R. Kahn, Sunyana Gadal, Neal Rosen, John J. Gaudino, Patrice A. Lee, Dylan P. Hartley, and S. Michael Rothenberg
Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer, Wei Yan, Rosa E. Menjivar, Monica E. Bonilla, Nina G. Steele, Samantha B. Kemp, Wenting Du, Katelyn L. Donahue, Kristee L. Brown, Eileen S. Carpenter, Faith R. Avritt, Valerie M. Irizarry-Negron, Sion Yang, William R. Burns, Yaqing Zhang, Marina Pasca di Magliano, and Filip Bednar
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration, Zeynep B. Zengin, Nicholas C. Henderson, Joseph J. Park, Alicia Ali, Charles Nguyen, Clara Hwang, Pedro C. Barata, Mehmet A. Bilen, Laura Graham, George Mo, Deepak Kilari, Abhishek Tripathi, Matthew Labriola, Shoshana Rothstein, Rohan Garje, Vadim S. Koshkin, Vaibhav G. Patel, Michael T. Schweizer, Andrew J. Armstrong, Rana R. McKay, Ajjai Alva, and Tanya Dorff
Altered histone acetylation patterns in pancreatic cancer cell lines induce subtype‑specific transcriptomic and phenotypical changes, Quan Zhou, Svenja Pichlmeier, Anna Maria Denz, Nicole Schreiner, Tobias Straub, Simone Benitz, Julia Wolff, Lisa Fahr, Maria Del Socorro Escobar Lopez, Jörg Kleeff, Julia Mayerle, Ujjwal Mukund Mahajan, and Ivonne Regel
Submissions from 2023
Outcomes of Patients with Thrombocytopenia Evaluated at Hematology Subspecialty Clinics, Zaid H. Abdel Rahman, Kevin C. Miller, Hiba Jabbour, Yaser Alkhatib, and Vijayalakshmi Donthireddy
Brief Report: Prognostic Relevance of 3q Amplification in Squamous Cell Carcinoma of the Lung, Fawzi Abu Rous, Pin Li, Shannon Carskadon, Sunny R. K Singh, Rebecca Chacko, Hassan Abushukair, Shirish M. Gadgeel, and Nallasivam Palanisamy
Challenges Faced by J-1 International Medical Graduates (IMGs) During COVID-19 Pandemic, Fawzi Abu Rous and Ivy Riano
Clinicopathologic characteristics of early-onset breast cancer: a comparative analysis of cases from across Ghana, Patrick Kafui Akakpo, Emmanuel Gustav Imbeah, Lawrence Edusei, Simon Naporo, Kofi Ulzen-Appiah, Joe Nat Clegg-Lamptey, Florence Dedey, Josephine Nsaful, Nelson Affram, Beatrice Wiafe, Samuel Mensah, Michael Nortey, Mohammed Sheriff, Forster Amponsah-Manu, Kwabena Agbedinu, and Evelyn M. Jiagge
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer, Mehmet Akce, Batoul Farran, Jeffrey M. Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Brian Olson, Walid L. Shaib, Christina Wu, Olatunji B. Alese, Maria Diab, Gregory B. Lesinski, and Bassel F. El-Rayes
A Rare Presentation of Concomitant Lung Disease and Hepatitis After Rituximab Treatment: A Case Report, Linda Albusoul, Hussna Abunafessa, and Vrushali Dabak
Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review, Lean Alkhatib, Lorena A. Velez Diaz, Samyukta Varma, Arsh Chowdhary, Prachi Bapat, Hai Pan, Geetika Kukreja, Prasannalaxmi Palabindela, Sri Abirami Selvam, and Kartik Kalra
Clinical Outcome in Patients With Early-Stage Small Cell Lung Cancer Treated With Surgery or Radiation in the Absence of Prophylactic Cranial Irradiation: A Single-Center Retrospective Study, Sondos Al Khatib, Khaled Adil, Lonni Schultz, Shirish M. Gadgeel, Andrew Popoff, Munther Ajlouni, Michael Simoff, Benjamin Movsas, and Aharon Feldman
Persistent Peri-Ablation Blood-Brain Barrier Opening After Laser Interstitial Thermal Therapy for Brain Tumors., Seamus Bartlett, Tavarekere N. Nagaraja, Brent Griffith, Katelynn G. Farmer, Meredith Van Harn, Sameah A. Haider, Rachel J. Hunt, Glauber Cabral, Robert A. Knight, Olivia G. Valadie, Stephen L. Brown, James R. Ewing, and Ian Y. Lee
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates, Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus, William H. Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M. Salay, Tracee L. McMiller, Marta M. Gilson, Changyu Wang, Mark Selby, Janis M. Taube, Robert Anders, Lieping Chen, Alan J. Korman, Drew M. Pardoll, Israel Lowy, and Suzanne L. Topalian
Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC), Amanda Broderick, Jinju Li, Alec Chu, Clara Hwang, Pedro C. Barata, Frank C. Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet A. Bilen, Deepak Kilari, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S. Koshkin, Elizabeth Pan, Tanya B. Dorff, Rana R. McKay, Michael T. Schweizer, Ajjai S. Alva, and Andrew J. Armstrong
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors, Michael A. Carducci, Ding Wang, Christina Habermehl, Matthias Bödding, Felix Rohdich, Floriane Lignet, Klaus Duecker, Oleksandr Karpenko, Linda Pudelko, Claude Gimmi, and Patricia LoRusso
KRT17High/CXCL8+ tumor cells display both classical and basal features and regulate myeloid infiltration in the pancreatic cancer microenvironment, Eileen S Carpenter, Padma Kadiyala, Ahmed M Elhossiny, Samantha B Kemp, Jay Li, Nina G. Steele, Rémy Nicolle, Zeribe C Nwosu, Julia Freeman, Henry Dai, Daniel Paglia, Wenting Du, Katelyn Donahue, Jacqueline Morales, Paola I Medina-Cabrera, Monica E Bonilla, Lindsey Harris, Stephanie The, Valerie Gunchick, Nicole Peterson, Kristee Brown, Michael Mattea, Carlos E Espinoza, Jake McGue, Sarah M Kabala, Rachel K Baliira, Nur M Renollet, Ayden G Mooney, Jianhua Liu, Sean Bhalla, Jeremy P Farida, Christopher Ko, Jorge D Machicado, Richard S Kwon, Erik-Jan Wamsteker, Allison Schulman, Michelle A Anderson, Ryan Law, Anoop Prabhu, Pierre A Coulombe, Arvind Rao, Timothy L Frankel, Filip Bednar, Jiaqi Shi, Vaibhav Sahai, and Marina Pasca di Magliano
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium, Toni K. Choueiri, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L. Schmidt, Gilberto de Lima Lopes, Clara Hwang, Sunny R. K Singh, Chinmay Jani, Lisa B. Weissmann, Elizabeth A. Griffiths, Susan Halabi, Ulysses Wu, Stephanie Berg, Timothy E. O'Connor, Trisha M. Wise-Draper, Orestis A. Panagiotou, Elizabeth J. Klein, Monika Joshi, Fares Yared, Miriam Santos Dutra, Na Tosha N. Gatson, Sibel Blau, Harpreet Singh, Rahul Nanchal, Rana R. McKay, Taylor K. Nonato, Ryann Quinn, Samuel M. Rubinstein, Matthew Puc, Blanche H. Mavromatis, Praveen Vikas, Bryan Faller, Howard A. Zaren, Salvatore Del Prete, Karen Russell, Daniel Y. Reuben, Melissa K. Accordino, Harpreet Singh, Christopher R. Friese, Sanjay Mishra, Donna R. Rivera, Yu Shyr, Dimitrios Farmakiotis, and Jeremy L. Warner
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer, Abigail C. Cornwell, Arwen A. Tisdale, Swati Venkat, Kathryn E. Maraszek, Abdulrahman A. Alahmari, Anthony George, Kristopher Attwood, Madison George, Donald Rempinski, Janusz Franco-Barraza, Mukund Seshadri, Mark D. Parker, Eduardo Cortes Gomez, Christos Fountzilas, Edna Cukierman, Nina G. Steele, and Michael E. Feigin
Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver, Anagha Deshpande, Javier Munoz, Katalin Kelemen, Vrushali Dabak, Amr Hanbali, and Razelle Kurzrock
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration, Tanya Dorff, Zeynep Zengin, Nicholas Henderson, Alicia Ali, Charles Nguyen, Clara Hwang, Pedro C Barata, Mehmet Bilen, Laura Graham, George Mo, Deepak Kilari, Abhishek Tripathi, Matthew Labriola, Shoshana Rothstein, Rohan Garje, Vadim Koshkin, Vaibhav Patel, Michael Schweizer, Andrew Armstrong, Rana McKay, and Ajjai Alva
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy, Alexander Drilon, Manish R. Sharma, Melissa L. Johnson, Timothy A. Yap, Shirish M. Gadgeel, Dale Nepert, Gang Feng, Micaela B. Reddy, Allison S. Harney, Mohamed Elsayed, Adam W. Cook, Christina E. Wong, Ronald J. Hinklin, Yutong Jiang, Eric N. Brown, Nickolas A. Neitzel, Ellen R. Laird, Wen-I Wu, Anurag Singh, Ping Wei, Keith A. Ching, John J. Gaudino, Patrice A. Lee, Dylan P. Hartley, and S. Michael Rothenberg
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022, Michel Ducreux, Ghassan K. Abou-Alfa, Tanios S. Bekaii-Saab, Jordan D. Berlin, Andrés Cervantes, Thierry de Baere, Cathy Eng, Peter Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Angela Lamarca, Pierre Laurent-Puig, Josep M. Llovet, Florian Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannova, Juan Manuel O'Connor, Eileen O'Reilly, Pia Österlund, Philip A. Philip, Gerald Prager, Erika Ruiz-Garcia, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, and Eric Van Cutsem
Neuropsychiatric disorders in adults undergoing chimeric antigen receptor T cells therapy for aggressive lymphomas and acute lymphoblastic leukemia, Josephine Emole, Odunayo Lawal, Oleksandra Lupak, Hemalatha Rangarajan, and Itoro Udo
Graft-versus-host disease: teaching old drugs new tricks at less cost, Shatha Farhan and Shernan G. Holtan
Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy, Genevieve A. Fasano, Solange Bayard, Yalei Chen, Jennifer Marti, Rache Simmons, Alexander Swistel, Jessica Bensenhaver, Melissa Davis, and Lisa Newman
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042), Shirish M. Gadgeel, Jieling Miao, Jonathan W. Riess, James Moon, Philip C. Mack, Gregory J. Gerstner, Timothy F. Burns, Asma Taj, Wallace L. Akerley, Konstantin H. Dragnev, Noel Laudi, Mary W. Redman, Jhanelle E. Gray, David R. Gandara, and Karen Kelly
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC, Marina C. Garassino, Shirish M. Gadgeel, Silvia Novello, Balazs Halmos, Enriqueta Felip, Giovanna Speranza, Rina Hui, Edward B. Garon, Hidehito Horinouchi, Shunichi Sugawara, Delvys Rodriguez-Abreu, Martin Reck, Razvan Cristescu, Deepti Aurora-Garg, Andrey Loboda, Jared Lunceford, Julie Kobie, Mark Ayers, Bilal Piperdi, M. Catherine Pietanza, and Luis Paz-Ares
Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study, Marina C. Garassino, Shirish M. Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban, Manuel Dómine, Maximilian J. Hochmair, Steven F. Powell, Helge G. Bischoff, Nir Peled, Francesco Grossi, Ross R. Jennens, Martin Reck, Rina Hui, Edward B. Garon, Takayasu Kurata, Jhanelle E. Gray, Paul Schwarzenberger, Erin Jensen, M. Catherine Pietanza, and Delvys Rodríguez-Abreu
A Case of Right Ventricular Failure Secondary to Acute Chest Syndrome Managed With Early Red Cell Exchange Transfusion, Abeselom Geletu, Josephine Emole, Alaa Abu Sayf, Oscar A. Hinojosa, and Alexandra Gastesi
Carcinoma En Cuirasse: A Rare but Striking Cutaneous Manifestation of Metastatic Breast Cancer, Manasi Godbole, Kashmira Wani, Shereen Q. Zia, and Vrushali Dabak
Sepsis-Related Outcomes of Patients with Philadelphia-Negative Myeloproliferative Neoplasms, Luis F. Gonzalez Mosquera, Bernard Moscoso, Pool Tobar, Diana Cardenas-Maldonado, Alida I. Podrumar, Ruben Mesa, and John A. Cuenca
Sepsis-related outcomes of patients with Philadelphia-negative myeloproliferative neoplasms, Luis F. Gonzalez Mosquera, Bernard Moscoso, Pool Tobar, Diana Cardenas-Maldonado, Alida I. Podrumar, Ruben Mesa, and John A. Cuenca
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19, Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K Shah, Rebecca Zon, Susan Alsamarai, Joy Awosika, Ziad El-Bakouny, Babar Bashir, Alicia Beeghly, Stephanie Berg, Daniel de-la-Rosa-Martinez, Deborah B. Doroshow, Pamela C. Egan, Joshua Fein, Daniel B. Flora, Christopher R. Friese, Ariel Fromowitz, Elizabeth A. Griffiths, Clara Hwang, Chinmay Jani, Monika Joshi, Hina Khan, Elizabeth J. Klein, Natalie Knox Heater, Vadim S. Koshkin, Daniel H. Kwon, Chris Labaki, Tahir Latif, Rana R. McKay, Gayathri Nagaraj, Elizabeth S. Nakasone, Taylor Nonato, Hyma V. Polimera, Matthew Puc, Pedram Razavi, Erika Ruiz-Garcia, Renee Maria Saliby, Aditi Shastri, Sunny R. K Singh, Vicky Tagalakis, Diana Vilar-Compte, Lisa B. Weissmann, Cy R. Wilkins, Trisha M. Wise-Draper, Michael T. Wotman, James J. Yoon, Sanjay Mishra, Petros Grivas, Yu Shyr, Jeremy L. Warner, Jean M. Connors, Dimpy P. Shah, and Rachel P. Rosovsky
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Non-Squamous Non-Small Cell Lung Cancer Progressing On/After Checkpoint Inhibitor Therapy or Chemotherapy, Kai He, David Berz, Shirish M. Gadgeel, Wade T. Iams, Debora S. Bruno, Collin M. Blakely, Alexander I. Spira, Manish R. Patel, David M. Waterhouse, Donald A. Richards, Anthony Pham, Robert Jotte, David S. Hong, Edward B. Garon, Anne Traynor, Peter Olson, Lisa Latven, Xiaohong Yan, Ronald Shazer, and Ticiana A. Leal
Cancer is chronic but antimicrobial stewardship is iconic: A retrospective cohort of optimal antibiotic use in ambulatory oncology clinics, Tiffany A. Ho, Katelyn M. Patterson, Shirish M. Gadgeel, Rachel M. Kenney, and Michael P. Veve
A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma, Jessica Hung, Samantha M. Perez, Siva Sai Krishna Dasa, Sarah P. Hall, Danielle B. Heckert, Brian P. Murphy, Howard C. Crawford, Kimberly A. Kelly, and Lindsey T. Brinton
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer, Clara Hwang, Nicholas C. Henderson, Shih-Chun Chu, Brandon Holland, Frank C. Cackowski, Amanda B. Pilling, Albert Jang, Shoshana Rothstein, Matthew Labriola, Joseph J. Park, Alyssa Ghose, Mehmet A. Bilen, Seema Mustafa, Deepak Kilari, Michael J. Pierro, Bicky Thapa, Abhishek Tripathi, Rohan Garje, Aditya Ravindra, Vadim S. Koshkin, Erik Hernandez, Michael T. Schweizer, Andrew J. Armstrong, Rana R. McKay, Tanya B. Dorff, Ajjai S. Alva, and Pedro C. Barata
Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis, Monika A. Izano, Connor Sweetnam, Chenan Zhang, James L. Weese, Douglas Reding, Jonathan Treisman, Anand Patel, Bindu Potugari, Andrew Stafford, Frank M. Wolf, Mary Tran, Thomas D. Brown, and Shirish M. Gadgeel
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers, Evelyn M. Jiagge, Dexter X Jin, Justin Y Newberg, Tomin Perea-Chamblee, Kelly R Pekala, Christopher Fong, Michele Waters, David Ma, Yvonne Dei-Adomakoh, Gilles Erb, Kanika S Arora, Sophia L Maund, Njoki Njiraini, Atara Ntekim, Susie Kim, Xuechun Bai, Marlene Thomas, Ronwyn van Eeden, Priti Hegde, Justin Jee, Debyani Chakravarty, Nikolaus Schultz, Michael F Berger, Garrett M Frampton, Ethan S Sokol, and Jian Carrot-Zhang
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma, Douglas B. Johnson, Michael B. Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Joy Awosika, Ziad Bakouny, Chris Labaki, Renee Maria Saliby, Clara Hwang, Sunny R. K Singh, Nino Balanchivadze, Christopher R. Friese, Leslie A. Fecher, James J. Yoon, Brandon Hayes-Lattin, Mehmet A. Bilen, Cecilia A. Castellano, Gary H. Lyman, Lisa Tachiki, Sumit A. Shah, Michael J. Glover, Daniel B. Flora, Elizabeth Wulff-Burchfield, Anup Kasi, Saqib H. Abbasi, Dimitrios Farmakiotis, Kendra Viera, Elizabeth J. Klein, Lisa B. Weissman, Chinmay Jani, Matthew Puc, Catherine C. Fahey, Daniel Y. Reuben, Sanjay Mishra, Alicia Beeghly-Fadiel, Benjamin French, and Jeremy L. Warner
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy, Husain Yar Khan, Mandana Kamgar, Amro Aboukameel, Sahar Bannoura, Brian Y. Chung, Yiwei Li, Mohammed Najeeb Al Hallak, Philip A. Philip, Susan Tsai, Sanjeev Luther, William A. Hall, and Asfar S. Azmi
Race-Associated Genomic Correlates of Therapeutic Response in African American Patients With Non-Small-Cell Lung Cancer, Pin Li, Kaitlyn Kane, Frank M. Wolf, Anna B. Berry, Shirish M. Gadgeel, and Amanda B. Pilling
Powerful, scalable and resource-efficient meta-analysis of rare variant associations in large whole genome sequencing studies, Xihao Li, Corbin Quick, Hufeng Zhou, Sheila M Gaynor, Yaowu Liu, Han Chen, Margaret Sunitha Selvaraj, Ryan Sun, Rounak Dey, Donna K Arnett, Lawrence F Bielak, Joshua C Bis, John Blangero, Eric Boerwinkle, Donald W Bowden, Jennifer A Brody, Brian E Cade, Adolfo Correa, L Adrienne Cupples, Joanne E Curran, Paul S de Vries, Ravindranath Duggirala, Barry I Freedman, Harald H H Göring, Xiuqing Guo, Jeffrey Haessler, Rita R Kalyani, Charles Kooperberg, Brian G Kral, Leslie A Lange, Ani Manichaikul, Lisa W Martin, Stephen T McGarvey, Braxton D Mitchell, May E Montasser, Alanna C Morrison, Take Naseri, Jeffrey R O'Connell, Nicholette D Palmer, Patricia A Peyser, Bruce M Psaty, Laura M Raffield, Susan Redline, Alexander P Reiner, Muagututi'a Sefuiva Reupena, Kenneth M Rice, Stephen S Rich, Colleen M Sitlani, Jennifer A Smith, Kent D Taylor, Ramachandran S Vasan, Cristen J Willer, James G Wilson, Lisa R Yanek, Wei Zhao, Jerome I Rotter, Pradeep Natarajan, Gina M Peloso, Zilin Li, and Xihong Lin
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity, Shuang Lu, Hong Sun Kim, Yubo Cao, Karan Bedi, Lili Zhao, Ishwarya Venkata Narayanan, Brian Magnuson, Yumei Gu, Jing Yang, Zhujun Yi, Sepideh Babaniamansour, Sargis Shameon, Chang Xu, Michelle T. Paulsen, Ping Qiu, Sivakumar Jeyarajan, Mats Ljungman, Dafydd Thomas, Yali Dou, Howard C. Crawford, Marina Pasca di Magliano, Kai Ge, Bo Yang, and Jiaqi Shi
